meropenem bradex 1 g
bradex s.a., pharmaceutical products - meropenemtrihydrat - pulver til injeksjons-/infusjonsvæske, oppløsning - 1 g
meropenem bradex 500 mg
bradex s.a., pharmaceutical products - meropenemtrihydrat - pulver til injeksjons-/infusjonsvæske, oppløsning - 500 mg
krystexxa
crealta pharmaceuticals ireland limited - pegloticase - gikt - antigout preparater - krystexxa er indisert for behandling av alvorlig ødeleggende kroniske tophaceous gikt hos voksne pasienter som har også erosive felles engasjement og som har mislyktes i å normalisere serum urinsyre med xantin oksidase hemmere nådd medisinsk passende dose eller som disse legemidlene er kontraindisert.
nitrolingual 0.4 mg/ dose
g. pohl-boskamp gmbh & co. - glyseryltrinitrat - sublingvalspray - 0.4 mg/ dose
meropenem sun 1 g
sun pharmaceutical - nederland - meropenemtrihydrat - pulver til injeksjons-/infusjonsvæske, oppløsning - 1 g
meropenem sun 500 mg
sun pharmaceutical - nederland - meropenemtrihydrat - pulver til injeksjons-/infusjonsvæske, oppløsning - 500 mg
prevexxion rn+hvt+ibd
boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kylling - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.
vectormune fp ilt
ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kylling - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.
fulvestrant sun 250 mg
sun pharmaceutical - nederland - fulvestrant - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 250 mg
livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirusinfeksjoner - antivirale midler til systemisk bruk - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). det bør vurderes å offisielle retningslinjer for riktig bruk av antivirale midler.